contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


fidelio-issues-call-options-to-vimians-chairman-of-the-board-magnus-welander

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Vimian Group är en koncern verksam inom djurhälsa. Bolaget levererar via sina dotterbolag läkemedel och tekniska lösningar till veterinärer, laboratorier och husdjursägare. Produkterna inkluderar exempelvis läkemedel med tillhörande klinisk forskning samt digitala plattformar för veterinärkliniker. Bolaget är verksamma på en global nivå med huvudkontor i Stockholm.

Vimian Group

Vimian Group AB (publ) has been informed that the Company’s largest shareholder Fidelio Vet Holding AB (“Fidelio”) has undertaken to issue 100,000 call options in Vimian to Magnus Welander, ...

<div class="mfn-preamble"><p><strong>Vimian Group AB (publ) has been informed that the Company’s largest shareholder Fidelio Vet Holding AB (“Fidelio”) has undertaken to issue 100,000 call options in Vimian to Magnus Welander, Chairman of the Board in Vimian Group AB (publ).</strong></p></div><div class="mfn-body"><p>The call options are being issued on market terms and are exercisable into 100,000 shares in Vimian after five years, in three tranches with an exercise price corresponding to SEK 33.16 subject to an annual step-up in exercise price of 5, 10 and 15 percent, respectively, starting on 27 June 2024.</p><p>The call options will not dilute the holdings of other shareholders and do not entail any costs for Vimian.</p><p>Today, Fidelio owns approximately 297,128,581 shares in Vimian, corresponding to 57% of the shares in Vimian Group AB (publ). Magnus Welander currently owns 73,630 shares in Vimian Group AB (publ).</p></div><div class="mfn-footer mfn-contacts mfn-ddfb1f46825b"><p><strong class="mfn-heading-1">For further information, please contact:</strong></p><hr><p><strong>Maria Dahllöf Tullberg</strong><br>Head of IR, Communications &amp; Sustainability<br><a rel="noopener" href="mailto:maria.tullberg@vimian.com">maria.tullberg@vimian.com</a><br>+46 736 26 88 86</p></div><div class="mfn-footer mfn-about mfn-b6e2606a1fc5"><p><strong class="mfn-heading-1">About Vimian</strong></p><hr><p>Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: <a rel="noopener" href="http://www.vimian.com.">www.vimian.com.</a> FNCA Sweden AB is appointed the Company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/a99cb44b-15d0-47f7-b569-4986d0a4d1f3/fidelio-issues-call-options-to-vimians-chairman-of-the-board-magnus-welander.pdf" class="mfn-generated mfn-primary">Fidelio issues call options to Vimian’s Chairman of the Board Magnus Welander</a></p></div>

Beställ vårt nyhetsbrev — inget användarkonto krävs!